Phenotypically, patients with an <i>HNF4A</i>-MODY tend to have early-onset diabetes, microvascular complications, low triglyceride levels, increased birth weight, fetal macrosomia, and less commonly neonatal hyperinsulinemic hypoglycemia. The gene discussed is HNF4A; the disease is hyperinsulinemic hypoglycemia.